BTG Share PerformanceMore

52 week high764.6 20/10/17
52 week low528.4 31/01/17
52 week change 60.0 (8.68%)
4 week volume10,117,239 26/09/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Declaration

RNS Number: 7531T BTG PLC 17 October 2017 BTG plc 17 October 2017 Director Declaration BTG plc announces today that Mr Giles Kerr, Non-executive Director of the Company, has been appointed as a Non-executive Director and Audit Committee Chair of Arix Bioscience plc with effect from 17 October 2017. This announcement is made pursuant to Listing Rule...

BTG acquires Roxwood; reiterates sales guidance

BTG, the global specialist healthcare company, has acquired Roxwood Medical, an innovative provider of advanced cardio...

Close Period Update

RNS Number: 7474S BTG PLC 05 October 2017 BTG plc: close period update London, UK, 5 October 2017: BTG plc (LSE: BTG), the global specialist healthcare company, provides the following update for the six months ended 30 September 2017 ahead of publication of its Interim Results on 14 November 2017. BTG has delivered a good performance in the first half of t...

BTG acquires Roxwood Medical

RNS Number: 7489S BTG PLC 05 October 2017 BTG plc acquires Roxwood Medical London, UK, 5 October 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Roxwood Medical ("Roxwood"), an innovative provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary a...

Block listing Interim Review

RNS Number: 7192S BTG PLC 04 October 2017 4 October 2017 BLOCK LISTING RETURN For period 4 April 2017 to 4 October 2017 Name of applicant: BTG plc Name of scheme BTG Executive Share Option Scheme BTG Performance Share Plan BTG Sharesave Scheme BTG US Stock Purchase Plan Total Balance under scheme from previous return 1,090,169 119,72...

Total Voting Rights

RNS Number: 4623S BTG PLC 02 October 2017 2 October 2017 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 2 October 2017: 1. the Company's issued share capital consists of 386,361,950 Ordinaryshares of 10p each admitted to trading, and each with one vote...

BTG ordered to pay $55.8m damages

BTG has been ordered to pay damages of $55.8m after a court ruled that the group had breached a distribution agreement...

Legal Ruling

RNS Number: 2225R BTG PLC 20 September 2017 BTG plc: legal ruling London, UK, 20 September 2017: BTG plc (LSE: BTG), the global specialist healthcare company, announces that a Memorandum Opinion has been issued by the Court of Chancery of Delaware ruling against BTG in its previously announced litigation with Wellstat Therapeutics Corporation conc...

Fundamental DataMore

P/E ratio86.322
Dividend yield0 %

Latest discussion posts More

  • Re: Enlightenment

    Great report. Good explanation as to why share price has recently picked up. I am amazed how thin the free float of shares is after you ignore the institutions and insider ...
    Mike Land
  • Re: Enlightenment

    BTG Analysis.......
  • Re: BTG, Yearly Chart Breakout..........

    Nothing to do with a chart, everything to do with information that Zytiga is performing better than expected and it will be receiving nice royalties. Information and newsflow ...
    Tricky Rich

Users' HoldingsMore

Users who hold BTG also hold..

Codes & Symbols